bioRxivBioengineeringPreprint
DNA origami assembled spheroid for evaluating cytotoxicity and infiltration of chimeric antigen receptor macrophage (CAR-M)
J. Liu, X. He, Q. Zhu, H. Wang, X. Shan, Y. Zhao, L. Zhang, G. Song, X. Yin
Abstract
Chimeric antigen receptor (CAR) T-cell therapies have shown remarkable results in patients with hematological malignancies. However, their success in treating solid tumors has been limited. As an alternative candidate for the CAR approach, CAR-macrophages (CAR-M) have demonstrated activation and phagocytosis directed by tumor antigens, showing promise in the treatment of solid tumors. Nevertheless, the mechanisms by which CARs direct tumor chemotaxis and invasion of CAR-M remain poorly understood. In this study, we aim to investigate the role of CARs in CAR-M attachment and infiltration using 3D tumor micro-spheroids, which were created by utilizing a novel nucleic acid nanostructures decorated living cells (NACs) based origami assembly technique. First, the effectiveness of phagocytosis and killing conducted by CAR-M was validated in the conventional 2D well/plate-surface culture models. Then,peripheral blood mononuclear cell (PBMC) invasion assay confirmed that the 3D tumor micro-spheroids were feasible for cell invasion. Finally, our results demonstrated that CAR-M exhibited higher invasion and killing capacity in 3D tumor micro-spheroids. In summary, the 3D NACs-origami assembled tumor spheroid model provides a suitable platform for target screening and pharmacodynamic evaluation of CAR-M.
- research focus: cell type annotation
- research focus: drug response / drug discovery
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CAR-Engineered Human Hematopoietic Stem Cell Macrophages Control Solid Tumors
Ian Ovider, Lívia Furquim de Castro, … Rodrigo Nalio Ramos·bioRxiv·May 29, 2026
- CAR-MACROPHAGES ACTIVATE ANTI TUMOR T CELLS IN THE ABSENCE OF PHAGOCYTOSIS
Lea C. Feldmann, Amaury Vaysse, … Capucine L. Grandjean·bioRxiv·Aug 28, 2026
- CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under control of antigen sensing in microwell arrays
Youngbin Cho, Matthew S. Laird, … Ioannis K. Zervantonakis·APL BioengineeringPeer-reviewed·Jul 23, 2024
- Assessment of CAR-T mediated and targeted cytotoxicity in 3D microfluidic TBNC co-culture models for combination therapy
K. A. F. Paterson, S. Paterson, … M. Zagnoni·bioRxiv·Sep 14, 2021
- CSPG4-targeting CAR-macrophages inhibit melanoma growth
Daniel Greiner, Qian Xue, … Minna Roh‐Johnson·OncogenePeer-reviewed·Mar 13, 2025
- An in situ generated CAR-M with IFNg and negative dominance Sirpa isoform augments hepatocellular carcinoma immunotherapy
Xiang Li, Jing Hu, … Panpan Zhang·Journal of NanobiotechnologyPeer-reviewed·May 26, 2026